Robert E Lyon

Suggest Changes
Learn More
OBJECTIVES We sought to determine whether matrix metalloproteinase (MMP) inhibitor, PG-116800, reduced left ventricular (LV) remodeling after myocardial infarction (MI). BACKGROUND PG-116800 is an(More)
  • 1